3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
52
Breast Neoplasms
24
Lung Neoplasms
21
Triple Negative Breast Neoplasms
16
Neoplasm Metastasis
16
Pancreatic Neoplasms
15
Neoplasms
15
Colorectal Neoplasms
14
Stomach Neoplasms
13
Head and Neck Neoplasms
12
Esophageal Neoplasms
12
Esophageal Squamous Cell Carcinoma
11
Uterine Cervical Neoplasms
10
Squamous Cell Carcinoma of Head and Neck
10
Small Cell Lung Carcinoma
9
Rectal Neoplasms
8
Ovarian Neoplasms
8
Leukemia, Myeloid, Acute
8
Recurrence
7
Nasopharyngeal Carcinoma
7
Glioblastoma
5
Fallopian Tube Neoplasms
5
Cholangiocarcinoma
5
Urinary Bladder Neoplasms
4
Sarcoma
4
Oropharyngeal Neoplasms
4
Mouth Neoplasms
4
Lymphoma
4
Endometrial Neoplasms
4
Colonic Neoplasms
4
Interventions
Gemcitabine
11
Cisplatin
10
pembrolizumab
5
Oxaliplatin
4
durvalumab
3
Magnetic Resonance Spectroscopy
3
Leucovorin
3
Fluorouracil
3
tivozanib
2
Specimen Handling
2
Capecitabine
2
zimberelimab
1
trametinib
1
tislelizumab
1
quemliclustat
1
pertuzumab
1
olaparib
1
irinotecan sucrosofate
1
atezolizumab
1
anlotinib
1
Yttrium-90
1
Tissue Adhesives
1
Tegafur
1
Stents
1
S 1 (combination)
1
Ritonavir
1
Radiosurgery
1
Pancreaticojejunostomy
1
Pancreaticoduodenectomy
1
Nivolumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Bile Duct Neoplasms
×
Drug Therapy
×
1 year
×
Clear all
No trials found.